Soleo Health Holdings, Inc.

Soleo Health is a leading national provider of complex specialty pharmacy services and infusion therapy, founded in 2014 and headquartered in Frisco, Texas. The company's mission is to be the unmatched leader in delivering exceptional care for patients receiving complex therapies across diverse sites of care, emphasizing the simplification of complex healthcare for its patients.

The company specializes in providing personalized care for patients with complex, rare, and ultra-rare diseases, offering services such as biopharmaceutical medications for conditions including bleeding disorders, primary immunodeficiencies, multiple sclerosis, Crohn's disease, and rheumatoid arthritis. Soleo Health operates a nationwide network of 26 to 28 pharmacy locations and over 30 to 40 ambulatory infusion suites, holding pharmacy licensure in all 50 states and providing national nursing coverage. The company is accredited by URAC for Specialty Pharmacy, ACHC (with Distinction in Rare Diseases and Orphan Drugs), the National Association of Boards of Pharmacy, and The Joint Commission.

In recent developments, Soleo Health launched SoleoRare™, a dedicated Rare Disease Specialty Pharmacy, in April 2026, and appointed Joy Rowan as Senior Vice President of Sales. The company also expanded its footprint with new ambulatory infusion centers in Austin, Texas, and Herndon, Virginia, in late 2025 and early 2026. Drew Walk serves as the CEO, with Holly Flax recently promoted to Chief Operating Officer. In February 2025, Soleo Health was acquired by private equity firms Court Square Capital Partners and WindRose Health Investors from its previous owner, H.I.G. Capital, positioning it for continued growth and expansion in the specialty healthcare market.